Projektbeschreibung
Weichgewebenavigation: Forschungsnachwuchs aus Biomedizintechnik und Medizin entwickelt neue Lösungen
Die Navigation durch das Weichgewebe bei chirurgischen Eingriffen, insbesondere bei der chirurgischen Resektion von Tumoren, wird durch die schwierige Aufgabe erschwert, mit der gewünschten Genauigkeit verformbare Organe zu erreichen, die sich als Reaktion auf Atmung, Herzschlag und den Eingriff selbst bewegen. Viele Patientinnen und Patienten mit hepatozellulärem Karzinom, der Hauptart von primärem Leberkrebs, kommen für eine Resektion nicht in Frage, und die Prognose anderer Personen wird durch die Herausforderungen bei der Weichteilnavigation beeinträchtigt. Im Rahmen des durch die Marie-Skłodowska-Curie-Maßnahmen unterstützten Projekts HiPerNav werden Nachwuchsforschende in den Bereichen minimalinvasive Behandlung, Biomedizintechnik, Forschungsmethoden und Unternehmertum weitergebildet. Die Forschung wird die Kluft zwischen theoretischen Ideen und der klinischen Praxis überbrücken, wobei Prototypen erprobt sowie reale Lösungen und Instrumente entwickelt werden.
Ziel
Primary liver cancer, which consists predominantly of hepatocellular carcinoma (HCC), is the fifth most common cancer worldwide and the third most common cause of cancer mortality. A successful surgical resection of HCC requires complete removal of the tumour while sparing as much healthy tissue as possible. Due to technical and clinical difficulties relatively low percentage of patients are eligible for resection. There is an urgent need to increase the patient eligibility and improve the survival prognosis after liver interventions. HiPerNav will train early stage researchers (biomedical engineers and medical doctors) to become international leading in key areas of expertise through a novel coordinated plan of individual research projects addressing specific bottlenecks in soft tissue navigation for improved treatment of liver cancer. The multi-disciplinary dialogue and work between clinicians and biomedical engineers is crucial to address these bottlenecks. By providing researchers with knowledge and training within specific topics from minimally invasive treatment, biomedical engineering, research methodologies, innovation and entrepreneurship, the link between academic research and industry will be strengthened. This allows for easy transfer of promising results from the research projects to commercially exploitable solutions. The global image guided surgery devices market is promising; it was valued at USD 2.76 billion in 2013 and is projected to expand 6.4% from 2014 to 2022 to reach USD 4.80 billion in 2022. The market for soft-tissue navigation is still in its infancy, mainly due to challenges in achieved accuracy for targeting deformable and moving organs. By providing multi-disciplinary training, the researchers in this consortium of international leading research institutions, universities and industry will initiate true translational research from academic theoretical ideas to the clinical testing of prototype, developed solutions and tools.
Wissenschaftliches Gebiet
- medical and health sciencesmedical biotechnology
- medical and health sciencesclinical medicineoncologyliver cancer
- medical and health sciencesbasic medicineanatomy and morphology
- medical and health sciencesclinical medicinesurgerysurgical specialties
- medical and health sciencesclinical medicineoncologypancreatic cancer
Programm/Programme
Thema/Themen
Aufforderung zur Vorschlagseinreichung
Andere Projekte für diesen Aufruf anzeigenFinanzierungsplan
MSCA-ITN-ETN - European Training NetworksKoordinator
0450 Oslo
Norwegen